爱美客(300896.SZ)：米诺地尔搽剂取得药品注册证书

Core Viewpoint - Aimeike (300896.SZ) announced that its wholly-owned subsidiary, Beijing Nobot Biotechnology Co., Ltd. (referred to as "Nobot"), has received approval from the National Medical Products Administration for the registration of Minoxidil topical solution in 2% and 5% concentrations, which are non-prescription dermatological medications [1] Group 1 - The 2% concentration is indicated for the treatment of androgenetic alopecia and alopecia areata [1] - The 5% concentration is restricted for use in males only, specifically for treating androgenetic alopecia and alopecia areata [1] - Minoxidil is a peripheral vasodilator that, when used topically over a long period, can stimulate hair growth in patients with androgenetic alopecia and alopecia areata [1]